Immunosuppressant-Loaded Nanoparticles Treat Symptoms Of Duchenne Muscular Dystrophy In Mice, Washington University School of Medicine Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Duchenne muscular dystrophy is a congenital disease that affects boys almost exclusively (“Jerry’s kids“) and leads to severe muscle dysfunction and death. Current therapies, primarily corticosteroids, are very limited in effectiveness – and introduce their own side effects that can make things worse. Now researchers at Washington University School of Medicine in St. Louis are reporting on a new technique that involves introducing nanoparticles – stuffed with rapamycin – to alleviate some of the symptoms of the disease.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news